This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Multz, A. S. Search for Related Content PubMed PubMed Citation Articles by Multz, A. S. Related Collections Critical Care Pharmacology

---

ANESTHETIC PHARMACOLOGY

Prolonged Dexmedetomidine Infusion as an Adjunct in Treating Sedation-Induced Withdrawal

Long Island Jewish Medical Center, New Hyde Park, New York

Address correspondence and reprint requests to Alan S. Multz, MD, Medical ICU, Long Island Jewish Medical Center, 270-05 76th Ave., New Hyde Park, NY 11040. Address e-mail to amultz{at}lij.edu

IMPLICATIONS: Dexmedetomidine, an ₂-adrenoceptor agonist, is indicated for sedating patients on mechanical ventilation. It has been approved by the Food and Drug Administration for 24-h use. This is a report concerning a patient in whom a continuous infusion of dexmedetomidine was safely used for a week to help in averting frank withdrawal symptoms from an opioid and benzodiazepines.

This article has been cited by other articles:

				B. L Honey, R. J Benefield, J. L Miller, and P. N Johnson {alpha}2-Receptor Agonists for Treatment and Prevention of Iatrogenic Opioid Abstinence Syndrome in Critically Ill Patients Ann. Pharmacother., September 1, 2009; 43(9): 1506 - 1511. [Abstract] [Full Text] [PDF]

				M. Klimek and M. M. Lacroix The Safety and Effectiveness of Dexmedetomidine When Used for More Than 24 Hours in an Adult Intensive Care Setting Journal of Pharmacy Practice, December 1, 2007; 20(6): 474 - 477. [Abstract] [PDF]

				N. K. Girgin, R. Iscimen, A. Gurbet, F. Kahveci, and O. Kutlay Dexmedetomidine sedation for the treatment of tetanus in the intensive care unit Br. J. Anaesth., October 1, 2007; 99(4): 599 - 600. [Full Text] [PDF]

				A. T Gerlach and J. F Dasta Dexmedetomidine: An Updated Review Ann. Pharmacother., February 1, 2007; 41(2): 245 - 252. [Abstract] [Full Text] [PDF]

				K. Baddigam, P. Russo, J. Russo, and J. D. Tobias Dexmedetomidine in the Treatment of Withdrawal Syndromes in Cardiothoracic Surgery Patients J Intensive Care Med, March 1, 2005; 20(2): 118 - 123. [Abstract] [PDF]

				J. F Dasta, S. L Kane-Gill, and A. J Durtschi Comparing Dexmedetomidine Prescribing Patterns and Safety in the Naturalistic Setting Versus Published Data Ann. Pharmacother., July 1, 2004; 38(7): 1130 - 1135. [Abstract] [Full Text] [PDF]

				J. C. Finkel and A. Elrefai The Use of Dexmedetomidine to Facilitate Opioid and Benzodiazepine Detoxification in an Infant Anesth. Analg., June 1, 2004; 98(6): 1658 - 1659. [Abstract] [Full Text] [PDF]